Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,227 | 471 | 1,126 | 304 | N/A |
| Receivables | 1,002 | 498 | 349 | 375 | N/A |
| Inventories | 1,423 | 923 | 712 | 498 | N/A |
| TOTAL | $4,895 | $2,008 | $2,299 | $1,237 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,303 | 1,203 | 1,294 | 1,133 | N/A |
| Intangibles | 278 | 322 | 445 | 487 | 0 |
| Other Non-Current Assets | 31 | 32 | 45 | 64 | 0 |
| TOTAL | $1,612 | $1,557 | $1,784 | $1,684 | $N/A |
| Total Assets | $6,507 | $3,565 | $4,083 | $2,921 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 515 | 548 | 444 | 501 | 0 |
| Accrued Expenses | 371 | 270 | 338 | 352 | N/A |
| Other current liabilities | 112 | 1,305 | 1,213 | 1,286 | N/A |
| TOTAL | $1,139 | $2,187 | $2,073 | $2,213 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 63 | 36 | N/A | N/A | N/A |
| TOTAL | $432 | $330 | $261 | $312 | $N/A |
| Total Liabilities | $1,571 | $2,518 | $2,334 | $2,524 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,371 | 9,612 | 9,612 | N/A | N/A |
| Common Shares | 61 | 29 | 29 | 27 | N/A |
| Retained earnings | -10,159 | -8,108 | -7,200 | -5,096 | N/A |
| TOTAL | $4,936 | $1,048 | $1,749 | $396 | $N/A |
| Total Liabilities And Equity | $6,507 | $3,565 | $4,083 | $2,921 | $0 |